(Q44332524)

2 December 2017

title

Development of a LC method for pharmaceutical quality control of the antimetastatic ruthenium complex NAMI-A. (English)

1 reference

2 December 2017

0 references

4

1 reference

2 December 2017

8

Jos H Beijnen

1 reference

2 December 2017

Marjan Bouma

1

1 reference

2 December 2017

Bastiaan Nuijen

2

1 reference

2 December 2017

Martine T Jansen

3

1 reference

2 December 2017

Fabrizio Picotti

5

1 reference

2 December 2017

Antonella Flaibani

6

1 reference

2 December 2017

Auke Bult

7

1 reference

2 December 2017

publication date

1 February 2003

1 reference

Journal of Pharmaceutical and Biomedical Analysis

2 December 2017

published in

1 reference

2 December 2017

volume

31

1 reference

2 December 2017

issue

2

1 reference

2 December 2017

page(s)

215-228

1 reference

Pharmacological control of lung metastases of solid tumours by a novel ruthenium complex

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900313-8

7 January 2021

Blood concentration and toxicity of the antimetastasis agent NAMI-A following repeated intravenous treatment in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900313-8

7 January 2021

Validated method for the determination of the novel organo-ruthenium anticancer drug NAMI-A in human biological fluids by Zeeman atomic absorption spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900313-8

7 January 2021

Water-Soluble Ruthenium(III)-Dimethyl Sulfoxide Complexes: Chemical Behaviour and Pharmaceutical Properties

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900313-8

7 January 2021

Development of HPLC conditions for valid determination of hydrolysis products of cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2802%2900313-8

7 January 2021

10.1016/S0731-7085(02)00313-8

Identifiers

DOI

1 reference

2 December 2017

1 reference